Review
Open access
Oct 2026
Proteomics in Antitumor Drug Target Discovery, Toxicity, Resistance, and Precision Oncology
Proteomics strategies are discussed, which enable the profiling of adverse drug reactions, the dissection of resistance mechanisms, and the advancement of precision oncology in antitumor drug development and precision oncology.
Qiang-Feng Zhong, Xiu-Li Wu, E. Wiechec et al.
· Drug Design, Development and... · 0 citations